Adial Pharmaceuticals, Inc. Debt Instrument, Periodic Payment
Adial Pharmaceuticals, Inc. (ADIL) reported Debt Instrument, Periodic Payment of $143.69 thousand for the 6-month period ending 2023-06-30, per its 10-Q filed 2023-08-21.
Discontinued › Notes › Debt › Debt Instruments
us-gaap:DebtInstrumentPeriodicPayment · last filed 2023-08-21
- Adial Pharmaceuticals, Inc. debt instrument, periodic payment for the quarter ending 2023-06-30 was $0.00.
- Adial Pharmaceuticals, Inc. debt instrument, periodic payment for the quarter ending 2023-03-31 was $143.69K.
| Period end | Debt Instrument, Periodic Payment 3 month | Debt Instrument, Periodic Payment 6 month |
|---|---|---|
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-21 | $143.69K 10-Q · filed 2023-08-21 |
| 2023-03-31 | $143.69K 10-Q · filed 2023-05-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |